共 237 条
[1]
Little EG(2012)Update on the current state of melanoma incidence Dermatol Clin 30 355-361
[2]
Eide MJ(2013)Targeting oncogenic drivers and the immune system in melanoma J Clin Oncol 31 499-506
[3]
McArthur GA(2011)Cancer immunotherapy comes of age Nature 480 480-489
[4]
Ribas A(2012)The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 252-264
[5]
Mellman I(2007)PD-1 and PD-1 ligands: from discovery to clinical application Int Immunol 19 813-824
[6]
Coukos G(2007)Melanoma biology and new targeted therapy Nature 445 851-857
[7]
Dranoff G(2012)Melanoma: new insights and new therapies J Invest Dermatol 132 854-863
[8]
Pardoll DM(2012)From genes to drugs: targeted strategies for melanoma Nat Rev Cancer 12 349-361
[9]
Okazaki T(2011)Ipilimumab: first global approval Drugs 71 1093-1104
[10]
Honjo T(2011)Ipilimumab plus dacarbazine for previously untreated metastatic melanoma N Engl J Med 364 2517-2526